Stop the presses, New York Methodist, a leader in cutting-edge diagnostics, now offers navigational bronchoscopy, a new option in the diagnosis and treatment of lung disease, which is the number one cause of cancer-related deaths in the United States — it claims more lives than colon, prostate and breast cancer combined! Holy moly. But the good news is that lung disease can be treated if caught in its earliest stage, which is where this new technology comes in handy. Until now, physicians relied on tried and true methods like CT scanning, x-rays, or sputum cytology (eek). If a mass was detected, a surgical biopsy was performed. But this minimally invasive new bronchoscopy uses a thin tube to evaluate the lungs — and then doctors can snip a sample for testing. “With navigational bronchoscopy, recovery is faster than for patients who have had more invasive biopsy procedures,” Dr. Suhail Raoof, chief of pulmonary medicine told us. As usual, New York Methodist is currently the only hospital in Brooklyn to offer this new procedure.
New York Methodist Hospital [506 Sixth St. between Seventh and Eighth avenues in Park Slope, (718) 780-3000].
Reach reporter Joanna DelBuono at email@example.com or by calling (718) 260-2523.